CIPHER PHARMACEUTICALS INC (CPH.TO)
Sells specialty pharmaceutical products treating acne, pain, heart conditions, and skin infections in Canada.
16.31-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+34.0%
The outlook
Cipher Pharmaceuticals is trading near the middle of its 52-week range with a mixed technical picture relative to its moving averages. Analysts on average see roughly 27% upside from current levels, and the stock trades at a trailing P/E of 9.7. The overall sentiment leans neutral.
What’s behind the score
Price trendMixed vs its moving averages
52-week range50% of the way from its 52-week low to high
Price targetAvg target +27% vs current price
Analyst price target
~12-month · 4 analysts20.64average target+26.5% vs now
Now 16.31
Low 17.00High 22.25
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
20.56
52-wk low
11.98
50-day avg
16.62
200-day avg
15.87
Trailing P/E
9.7